MOLLY MICKLE: Open Payments
NPI 1962126417 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 73 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $170 · 2025 $1,666
Food & beverage: $1,641Consulting: $25
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $517 |
| AstraZeneca Pharmaceuticals LP | 22 | $403 |
| Grifols USA, LLC | 6 | $155 |
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
| HARMONY BIOSCIENCES LLC | 3 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $89 |
| Pulmonx Corporation | 3 | $83 |
| Viatris Specialty LLC | 2 | $51 |
| Amgen Inc. | 2 | $42 |
| ADMA BioManufacturing LLC | 1 | $25 |
Products named: NUCALA, AIRSUPRA, Prolastin-C Liquid, DUPIXENT, TEZSPIRE, BREZTRI, WAKIX, CHARTIS CATHETER.
Industry payments across NY — which companies pay providers there.
